Open Access


Read more
image01

Online Manuscript Submission


Read more
image01

Submitted Manuscript Trail


Read more
image01

Online Payment


Read more
image01

Online Subscription


Read more
image01

Email Alert



Read more
image01

Original Research Article | OPEN ACCESS

Anti-proliferation and apoptosis effects of Camellia nitidissima C. W. Chi extract on A549 lung cancer cells

Zhi-hui Zhang1 , Pei Li2

1Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, 510315; 2Cancer Center, Nanfang Hospital/The First School of Clinical Medicine, Southern Medical University, 510515, Guangzhou, China.

For correspondence:-  Zhi-hui Zhang   Email: zhangzhihui020@126.com   Tel:+862061650124

Accepted: 21 February 2018        Published: 31 March 2018

Citation: Zhang Z, Li P. Anti-proliferation and apoptosis effects of Camellia nitidissima C. W. Chi extract on A549 lung cancer cells. Trop J Pharm Res 2018; 17(3):395-400 doi: 10.4314/tjpr.v17i3.2

© 2018 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To investigate the effect of Camellia nitidissima C. W. Chi extract (CNCE) on apoptosis and proliferation in A549 human lung cancer cells.
Methods: Inverted microscope was used to examine morphological changes in A549 cells after exposure to CNCE. Trypan blue staining of living cells was applied to construct the cell growth curve after treatment with varying concentrations of CNCE. The influence of CNCE on cell proliferation, apoptosis and cell cycle were determined by MTT assay. The protein expressions of key apoptosis-related enzymes were evaluated by immuno-cytochemical method. 
Results: CNCE inhibited the growth of A549 lung cancer cells at the concentration range of 20 - 160 μg/mL. Flow cytometry showed that CNCE induced apoptosis in the A549 cells. The proportion of cells in G0/G1-phase increased significantly (p < 0.01), while the proportion of cells in S-phase and G2/M-phase decreased correspondingly, indicating that the cells were in G0/G1-phase arrest. Cell cycle arrest and apoptosis-inducing effect gradually increased with increase in CNCE concentration. With increasing concentrations of CNCE, there were significant increases in the expressions of caspase-3 (p < 0.05), caspase-8 (p < 0.01) and caspase-9 (p < 0.05), and significant decreases in Ki-67 (p < 0.01) and p21 ras protein (p < 0.01).
Conclusion: CNCE exerts significant inhibitory effect on the proliferation of A549 lung cancer cells, and therefore can potentially be developed for the treatment of lung cancer

Keywords: Camellia nitidissima, Antitumor activity, Lung cancer, Apoptosis, Cell cycle arrest, Caspase

Impact Factor
Thompson Reuters (ISI): 0.523 (2021)
H-5 index (Google Scholar): 39 (2021)

Article Tools

Share this article with



Article status: Free
Fulltext in PDF
Similar articles in Google
Similar article in this Journal:

Archives

2024; 23: 
1,   2,   3,   4
2023; 22: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2022; 21: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2021; 20: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2020; 19: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2019; 18: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2018; 17: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2017; 16: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2016; 15: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2015; 14: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2014; 13: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2013; 12: 
1,   2,   3,   4,   5,   6
2012; 11: 
1,   2,   3,   4,   5,   6
2011; 10: 
1,   2,   3,   4,   5,   6
2010; 9: 
1,   2,   3,   4,   5,   6
2009; 8: 
1,   2,   3,   4,   5,   6
2008; 7: 
1,   2,   3,   4
2007; 6: 
1,   2,   3,   4
2006; 5: 
1,   2
2005; 4: 
1,   2
2004; 3: 
1
2003; 2: 
1,   2
2002; 1: 
1,   2

News Updates